{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:49:14Z","timestamp":1791928154686,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R03CA270677"],"award-info":[{"award-number":["R03CA270677"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Concerns about potential side effects remain a barrier to uptake of Food and Drug Administration-approved smoking cessation pharmacotherapy (ie, varenicline, bupropion, nicotine replacement therapy [NRT]). However, use of pharmacotherapy can double the odds of successful quitting. Knowledge of an individual\u2019s likelihood of side effects while taking smoking cessation pharmacotherapy could influence treatment planning discussions and monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a secondary, post hoc analysis to predict an individual\u2019s likelihood of adverse events (AEs) using the Evaluating Adverse Events in a Global Smoking Cessation Study data from 4209 adults in the United States who smoked. Participants were randomized to receive 12 weeks of treatment with varenicline, bupropion, NRT patch, or placebo. Our models predicted the likelihood of moderate to severe psychiatric and nonpsychiatric AEs during treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using pretreatment demographic and clinical data, multivariable logistic regression models yielded acceptable areas under the receiver operating characteristic curve for an individual\u2019s likelihood of moderate to severe (1) psychiatric AEs for bupropion and NRT and (2) nonpsychiatric AEs for varenicline and bupropion. Once we adjusted for demographic and baseline characteristics, medication was not associated with psychiatric AEs. Varenicline differed from placebo with regards to nonpsychiatric AEs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It is possible to predict person-specific likelihood of moderate to severe psychiatric and nonpsychiatric AEs during smoking cessation treatment, though the probability of psychiatric AEs did not differ by medication. Future work should consider factors related to implementation in clinical settings, including determining whether lower burden assessment protocols can be equally accurate for AE prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>Using data from a large dataset people who smoke in the United States, it is possible to predict an individual\u2019s likelihood of psychiatric and nonpsychiatric AEs during smoking cessation treatment prior to initiating treatment. These predictive models provide a starting point for future work addressing how best to modify and integrate such clinical decision support algorithms into treatment for smoking cessation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ntr\/ntae290","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T15:28:44Z","timestamp":1733758124000},"page":"839-848","source":"Crossref","is-referenced-by-count":3,"title":["Can We Predict Who Will Experience Adverse Events While Using Smoking Cessation Pharmacotherapy? A Secondary Analysis of the EAGLES Clinical Trial"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-5158","authenticated-orcid":false,"given":"Bethany J","family":"Wolf","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Medical University of South Carolina , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina , Charleston, SC ,","place":["USA"]},{"name":"Hollings Cancer Center, Medical University of South Carolina , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-9420","authenticated-orcid":false,"given":"Jennifer R","family":"Dahne","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina , Charleston, SC ,","place":["USA"]},{"name":"Hollings Cancer Center, Medical University of South Carolina , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6961-4399","authenticated-orcid":false,"given":"Rachel L","family":"Tomko","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina , Charleston, SC ,","place":["USA"]},{"name":"Hollings Cancer Center, Medical University of South Carolina , Charleston, SC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"issue":"18","key":"2025042201515796000_CIT0001","doi-asserted-by":"crossref","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults\u2014United States, 2021","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"3","key":"2025042201515796000_CIT0002","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.drugalcdep.2013.03.008","article-title":"Probability and predictors of relapse to smoking: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"132","author":"Garc\u00eda-Rodr\u00edguez","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"2025042201515796000_CIT0003","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.addbeh.2013.08.030","article-title":"Relapse among cigarette smokers: the CARDIA longitudinal study\u20141985-2011","volume":"39","author":"Caraballo","year":"2014","journal-title":"Addict Behav."},{"issue":"8","key":"2025042201515796000_CIT0004","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/add.14208","article-title":"Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES","volume":"113","author":"West","year":"2018","journal-title":"Addiction."},{"issue":"10037","key":"2025042201515796000_CIT0005","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet."},{"issue":"1","key":"2025042201515796000_CIT0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1360-0443.2012.04009.x","article-title":"Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) four country survey","volume":"108","author":"Kasza","year":"2013","journal-title":"Addiction."},{"issue":"52","key":"2025042201515796000_CIT0007","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting smoking among adults\u2014United States, 2000\u20132015","volume":"65","author":"Babb","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"10","key":"2025042201515796000_CIT0008","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/ntr\/ntab068","article-title":"Self-reported quit aids and assistance used by smokers at their most recent quit attempt: findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey","volume":"23","author":"Gravely","year":"2021","journal-title":"Nicotine Tob Res."},{"issue":"2","key":"2025042201515796000_CIT0009","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.amepre.2007.09.033","article-title":"Use of smoking-cessation treatments in the United States","volume":"34","author":"Shiffman","year":"2008","journal-title":"Am J Prev Med."},{"key":"2025042201515796000_CIT0010","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1186\/1471-2458-14-1182","article-title":"\u201cTobacco dependence treatment makes no sense because\u201d\u2026: rebuttal of commonly-heard arguments against providing tobacco dependence treatment in the hospital setting","volume":"14","author":"Balmford","year":"2014","journal-title":"BMC Public Health."},{"key":"2025042201515796000_CIT0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2458-8-129","article-title":"Reasons for not using smoking cessation aids","volume":"8","author":"Gross","year":"2008","journal-title":"BMC Public Health."},{"key":"2025042201515796000_CIT0012","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1186\/1471-2458-14-1311","article-title":"Nicotine replacement therapy use among smokers and ex-smokers: associated attitudes and beliefs: a qualitative study","volume":"14","author":"Silla","year":"2014","journal-title":"BMC Public Health."},{"issue":"2","key":"2025042201515796000_CIT0013","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/add.12778","article-title":"Use of stop-smoking medications in the United States before and after the introduction of varenicline","volume":"110","author":"Kasza","year":"2015","journal-title":"Addiction."},{"issue":"4","key":"2025042201515796000_CIT0014","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s41669-021-00274-7","article-title":"Smoking cessation pharmacotherapy utilization and costs to a Medicaid managed care plan","volume":"5","author":"Corelli","year":"2021","journal-title":"PharmacoEcon Open."},{"key":"2025042201515796000_CIT0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2017.03.021","article-title":"Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States","volume":"177","author":"Shah","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"2025042201515796000_CIT0016","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.mayocp.2020.10.046","article-title":"Frequently reported adverse events with smoking cessation medications: post hoc analysis of a randomized trial","volume":"96","author":"Ebbert","year":"2021","journal-title":"Mayo Clin Proc."},{"key":"2025042201515796000_CIT0017","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2020.01.013","article-title":"\u201cIsn\u2019t there a bunch of side effects?\u201d: a focus group study on the beliefs about cessation treatments of non-college educated young adult smokers","volume":"112","author":"Duarte","year":"2020","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"2025042201515796000_CIT0018","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1521\/aeap.2021.33.2.158","article-title":"Experiences with smoking cessation attempts and prior use of cessation aids in smokers with HIV: findings from a focus group study conducted in Durham, North Carolina","volume":"33","author":"Pacek","year":"2021","journal-title":"AIDS Educ Prev."},{"issue":"6","key":"2025042201515796000_CIT0019","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.3390\/ijerph120606591","article-title":"Why don\u2019t smokers want help to quit? A qualitative study of smokers\u2019 attitudes towards assisted vs. unassisted quitting","volume":"12","author":"Morphett","year":"2015","journal-title":"Int J Environ Res Public Health."},{"issue":"4","key":"2025042201515796000_CIT0020","doi-asserted-by":"crossref","first-page":"e007301","DOI":"10.1136\/bmjopen-2014-007301","article-title":"Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers","volume":"5","author":"Smith","year":"2015","journal-title":"BMJ Open."},{"issue":"6","key":"2025042201515796000_CIT0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s11606-019-04858-2","article-title":"Predictors of neuropsychiatric adverse events with smoking cessation medications in the randomized controlled EAGLES trial","volume":"34","author":"Anthenelli","year":"2019","journal-title":"J Gen Intern Med."},{"issue":"1","key":"2025042201515796000_CIT0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ntr\/ntr137","article-title":"Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence","volume":"14","author":"Fagerstr\u00f6m","year":"2012","journal-title":"Nicotine Tob Res."},{"issue":"6","key":"2025042201515796000_CIT0023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"2025042201515796000_CIT0024","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"7","key":"2025042201515796000_CIT0025","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"issue":"3","key":"2025042201515796000_CIT0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The agression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"J Pers Soc Psychol."},{"issue":"12","key":"2025042201515796000_CIT0027","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry."},{"key":"2025042201515796000_CIT0028","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I\/P)","author":"First","year":"2002"},{"key":"2025042201515796000_CIT0029","volume-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)","author":"First","year":"1997"},{"issue":"3","key":"2025042201515796000_CIT0030","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News."},{"key":"2025042201515796000_CIT0031","author":"R Core Team","year":"2023"},{"issue":"10","key":"2025042201515796000_CIT0032","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/add.15440","article-title":"Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors","volume":"116","author":"Beard","year":"2021","journal-title":"Addiction."},{"issue":"4","key":"2025042201515796000_CIT0033","doi-asserted-by":"crossref","first-page":"e0175383","DOI":"10.1371\/journal.pone.0175383","article-title":"Use of a machine learning framework to predict substance use disorder treatment success","volume":"12","author":"Acion","year":"2017","journal-title":"PLoS One."},{"key":"2025042201515796000_CIT0034","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jsat.2019.01.020","article-title":"Machine learning vs addiction therapists: a pilot study predicting alcohol dependence treatment outcome from patient data in behavior therapy with adjunctive medication","volume":"99","author":"Symons","year":"2019","journal-title":"J Subst Abuse Treat."},{"key":"2025042201515796000_CIT0035","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.invent.2019.100261","article-title":"Predictors of treatment response in a web-based intervention for cannabis users","volume":"18","author":"Jonas","year":"2019","journal-title":"Internet Interv."},{"issue":"3","key":"2025042201515796000_CIT0036","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ntr\/nty259","article-title":"A machine-learning approach to predicting smoking cessation treatment outcomes","volume":"22","author":"Coughlin","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"10","key":"2025042201515796000_CIT0037","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/add.16226","article-title":"Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders","volume":"118","author":"Tomko","year":"2023","journal-title":"Addiction."},{"key":"2025042201515796000_CIT0038","doi-asserted-by":"crossref","first-page":"111066","DOI":"10.1016\/j.drugalcdep.2023.111066","article-title":"Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning models","volume":"255","author":"Miranda","year":"2024","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"2025042201515796000_CIT0039","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/ntr\/ntz044","article-title":"Variants in the CHRNA5-CHRNA3-CHRNB4 region of chromosome 15 predict gastrointestinal adverse events in the transdisciplinary tobacco use research center smoking cessation trial","volume":"22","author":"Culverhouse","year":"2020","journal-title":"Nicotine Tob Res."},{"issue":"3","key":"2025042201515796000_CIT0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/npp.2011.232","article-title":"Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials","volume":"37","author":"King","year":"2012","journal-title":"Neuropsychopharmacology."}],"container-title":["Nicotine and Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntae290\/61200074\/ntae290.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/5\/839\/61200074\/ntae290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/27\/5\/839\/61200074\/ntae290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T01:52:20Z","timestamp":1745286740000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/27\/5\/839\/7920014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2025,4,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntae290","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,10]]}}}